Date: 2011-10-18
Type of information:
phase: 1
Announcement: initiation
Company: FORMAC Pharmaceuticals (Belgium)
Product: silica-based drug delivery platform
Action mechanism:
Disease:
Therapeutic area:
Country:
Trial details:
Latest
news: FormacPharmaceuticals has initiated a phase 1 Proof-of-Concept (PoC) clinical trial for its silica-based drug delivery platform. This phase 1 clinical trial follows the successful outcome of the preclinical assessment of Formac’s silica-based drug delivery of a very poorly soluble compound and will assess the bio-availability enhancing effect of its proprietary platform in healthy volunteers when compared to a commercially available formulation.
